518 related articles for article (PubMed ID: 18007026)
1. Toll-like receptor 4 mediates maladaptive left ventricular remodeling and impairs cardiac function after myocardial infarction.
Timmers L; Sluijter JP; van Keulen JK; Hoefer IE; Nederhoff MG; Goumans MJ; Doevendans PA; van Echteld CJ; Joles JA; Quax PH; Piek JJ; Pasterkamp G; de Kleijn DP
Circ Res; 2008 Feb; 102(2):257-64. PubMed ID: 18007026
[TBL] [Abstract][Full Text] [Related]
2. Targeted deletion of nuclear factor kappaB p50 enhances cardiac remodeling and dysfunction following myocardial infarction.
Timmers L; van Keulen JK; Hoefer IE; Meijs MF; van Middelaar B; den Ouden K; van Echteld CJ; Pasterkamp G; de Kleijn DP
Circ Res; 2009 Mar; 104(5):699-706. PubMed ID: 19168865
[TBL] [Abstract][Full Text] [Related]
3. Toll-like receptor-2 modulates ventricular remodeling after myocardial infarction.
Shishido T; Nozaki N; Yamaguchi S; Shibata Y; Nitobe J; Miyamoto T; Takahashi H; Arimoto T; Maeda K; Yamakawa M; Takeuchi O; Akira S; Takeishi Y; Kubota I
Circulation; 2003 Dec; 108(23):2905-10. PubMed ID: 14656915
[TBL] [Abstract][Full Text] [Related]
4. Critical role of the NAD(P)H oxidase subunit p47phox for left ventricular remodeling/dysfunction and survival after myocardial infarction.
Doerries C; Grote K; Hilfiker-Kleiner D; Luchtefeld M; Schaefer A; Holland SM; Sorrentino S; Manes C; Schieffer B; Drexler H; Landmesser U
Circ Res; 2007 Mar; 100(6):894-903. PubMed ID: 17332431
[TBL] [Abstract][Full Text] [Related]
5. Myocardial ischemia/reperfusion injury is mediated by leukocytic toll-like receptor-2 and reduced by systemic administration of a novel anti-toll-like receptor-2 antibody.
Arslan F; Smeets MB; O'Neill LA; Keogh B; McGuirk P; Timmers L; Tersteeg C; Hoefer IE; Doevendans PA; Pasterkamp G; de Kleijn DP
Circulation; 2010 Jan; 121(1):80-90. PubMed ID: 20026776
[TBL] [Abstract][Full Text] [Related]
6. Biglycan is required for adaptive remodeling after myocardial infarction.
Westermann D; Mersmann J; Melchior A; Freudenberger T; Petrik C; Schaefer L; Lüllmann-Rauch R; Lettau O; Jacoby C; Schrader J; Brand-Herrmann SM; Young MF; Schultheiss HP; Levkau B; Baba HA; Unger T; Zacharowski K; Tschöpe C; Fischer JW
Circulation; 2008 Mar; 117(10):1269-76. PubMed ID: 18299507
[TBL] [Abstract][Full Text] [Related]
7. Toll-like receptor 4 is involved in brain damage and inflammation after experimental stroke.
Caso JR; Pradillo JM; Hurtado O; Lorenzo P; Moro MA; Lizasoain I
Circulation; 2007 Mar; 115(12):1599-608. PubMed ID: 17372179
[TBL] [Abstract][Full Text] [Related]
8. Anti-monocyte chemoattractant protein-1 gene therapy attenuates left ventricular remodeling and failure after experimental myocardial infarction.
Hayashidani S; Tsutsui H; Shiomi T; Ikeuchi M; Matsusaka H; Suematsu N; Wen J; Egashira K; Takeshita A
Circulation; 2003 Oct; 108(17):2134-40. PubMed ID: 14517168
[TBL] [Abstract][Full Text] [Related]
9. TIMP-3 deficiency accelerates cardiac remodeling after myocardial infarction.
Tian H; Cimini M; Fedak PW; Altamentova S; Fazel S; Huang ML; Weisel RD; Li RK
J Mol Cell Cardiol; 2007 Dec; 43(6):733-43. PubMed ID: 17945252
[TBL] [Abstract][Full Text] [Related]
10. Extracellular matrix remodeling attenuated after experimental postinfarct left ventricular aneurysm repair.
Hsu CP; Huang CY; Wang JS; Sun PC; Shih CC
Ann Thorac Surg; 2008 Oct; 86(4):1243-9. PubMed ID: 18805169
[TBL] [Abstract][Full Text] [Related]
11. Increased toll-like receptor 4 in the myocardium of patients requiring left ventricular assist devices.
Birks EJ; Felkin LE; Banner NR; Khaghani A; Barton PJ; Yacoub MH
J Heart Lung Transplant; 2004 Feb; 23(2):228-35. PubMed ID: 14761771
[TBL] [Abstract][Full Text] [Related]
12. High dose aspirin and left ventricular remodeling after myocardial infarction: aspirin and myocardial infarction.
Adamek A; Hu K; Bayer B; Wagner H; Ertl G; Bauersachs J; Frantz S
Basic Res Cardiol; 2007 Jul; 102(4):334-40. PubMed ID: 17340057
[TBL] [Abstract][Full Text] [Related]
13. Activated toll-like receptor 4 in monocytes is associated with heart failure after acute myocardial infarction.
Satoh M; Shimoda Y; Maesawa C; Akatsu T; Ishikawa Y; Minami Y; Hiramori K; Nakamura M
Int J Cardiol; 2006 May; 109(2):226-34. PubMed ID: 16051384
[TBL] [Abstract][Full Text] [Related]
14. Heart function and cytokine expression is similar in mice and rats after myocardial infarction but differences occur in TNFalpha expression.
Deten A; Zimmer HG
Pflugers Arch; 2002 Nov; 445(2):289-96. PubMed ID: 12457250
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of endogenous Mst1 prevents apoptosis and cardiac dysfunction without affecting cardiac hypertrophy after myocardial infarction.
Odashima M; Usui S; Takagi H; Hong C; Liu J; Yokota M; Sadoshima J
Circ Res; 2007 May; 100(9):1344-52. PubMed ID: 17395874
[TBL] [Abstract][Full Text] [Related]
16. Atorvastatin enhances interleukin-10 levels and improves cardiac function in rats after acute myocardial infarction.
Stumpf C; Petzi S; Seybold K; Wasmeier G; Arnold M; Raaz D; Yilmaz A; Daniel WG; Garlichs CD
Clin Sci (Lond); 2009 Jan; 116(1):45-52. PubMed ID: 18459941
[TBL] [Abstract][Full Text] [Related]
17. Gelsolin regulates cardiac remodeling after myocardial infarction through DNase I-mediated apoptosis.
Li GH; Shi Y; Chen Y; Sun M; Sader S; Maekawa Y; Arab S; Dawood F; Chen M; De Couto G; Liu Y; Fukuoka M; Yang S; Da Shi M; Kirshenbaum LA; McCulloch CA; Liu P
Circ Res; 2009 Apr; 104(7):896-904. PubMed ID: 19246681
[TBL] [Abstract][Full Text] [Related]
18. Administration of a tumor necrosis factor inhibitor at the time of myocardial infarction attenuates subsequent ventricular remodeling.
Berry MF; Woo YJ; Pirolli TJ; Bish LT; Moise MA; Burdick JW; Morine KJ; Jayasankar V; Gardner TJ; Sweeney HL
J Heart Lung Transplant; 2004 Sep; 23(9):1061-8. PubMed ID: 15454172
[TBL] [Abstract][Full Text] [Related]
19. Etanercept or intravenous immunoglobulin attenuates expression of genes involved in post-myocardial infarction remodeling.
Gurantz D; Yndestad A; Halvorsen B; Lunde OV; Omens JH; Ueland T; Aukrust P; Moore CD; Kjekshus J; Greenberg BH
Cardiovasc Res; 2005 Jul; 67(1):106-15. PubMed ID: 15949474
[TBL] [Abstract][Full Text] [Related]
20. Cardiac overexpression of monocyte chemoattractant protein-1 in transgenic mice prevents cardiac dysfunction and remodeling after myocardial infarction.
Morimoto H; Takahashi M; Izawa A; Ise H; Hongo M; Kolattukudy PE; Ikeda U
Circ Res; 2006 Oct; 99(8):891-9. PubMed ID: 16990567
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]